HaemaLogiX Overview

  • Status
  • Private
  • Employees
  • 4
Employees
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

HaemaLogiX General Information

Description

Developer of novel immuno-oncology and immune-therapies intended for the treatment of haematologic malignancies and auto-immune diseases. The company's mmuno-oncology and immune-therapies enables blood cancers patient to have extended survival time from the disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • Suite 145
  • 4 Cornwallis Street
  • Eveleigh, New South Wales 2015
  • Australia
+61 (02) 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

HaemaLogiX Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view HaemaLogiX’s complete valuation and funding history, request access »

HaemaLogiX Executive Team (3)

Name Title Board Seat Contact Info
Bryce Carmine Chief Executive Officer & Chairman
Dimitra Korkidas Chief Financial Officer and Company Secretary
Rosanne Dunn Ph.D Director of Vice President, Clinical Research & Product Development and Board Member
To view HaemaLogiX’s complete executive team members history, request access »

HaemaLogiX Board Members (3)

Name Representing Role Since
Alan Liddle HaemaLogiX Board Member 000 0000
Bryce Carmine HaemaLogiX Chief Executive Officer & Chairman 000 0000
John Cullity HaemaLogiX Board Member 000 0000
To view HaemaLogiX’s complete board members history, request access »

HaemaLogiX Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HaemaLogiX Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Cicada Innovations Accelerator/Incubator Minority 000 0000 000000 0
To view HaemaLogiX’s complete investors history, request access »